Does albendazole affect seizure remission and computed tomography response in children with neurocysticercosis? A systematic review and meta-analysis

Journal of Child Neurology

Volumn 22, Issue 2, 2007, Pages 135-142

  Mazumdar, Maitreyi ^a   Pandharipande, Pari ^b   Poduri, Annapurna ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drug therapy; Epilepsy; Neurocysticercosis

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; PLACEBO; PRAZIQUANTEL; PREDNISOLONE; STEROID;

CHILD; CLINICAL TRIAL; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; DATA EXTRACTION; DRUG EFFICACY; DRUG RESPONSE; EMBASE; HUMAN; MEDLINE; META ANALYSIS; NEUROCYSTICERCOSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SYSTEMATIC REVIEW;

ALBENDAZOLE; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; HUMANS; NEUROCYSTICERCOSIS; SEIZURES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249845918     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807300295     Document Type: Review

References (28)

1. Garcia HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am. 2000; 14: 97-119, ix.
2. Mitchell WG, Snodgrass SR Intraparenchymal cerebral cysticercosis in children: A benign prognosis. Pediatr Neurol. 1985; 1: 151-156.
3. Wallin MT, Kurtzke JF Neurocysticercosis in the United States: Review of an important emerging infection. Neurology. 2004; 63: 1559-1564.
4. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004; 350: 249-258.
5. Sotelo J. Neurocysticercosis-is the elimination of parasites beneficial? N Engl J Med. 2004; 350: 280-282.
6. Del Brutto OH, Rajshekhar V., White ACJr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001; 57: 177-183.
7. Jadad AR, Cook DJ, Browman GP A guide to interpreting discordant systematic reviews. CMAJ. 1997; 156: 1411-1416.
8. Baranwal AK, Singhi PD, Khandelwal N., Singhi SC Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: A randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J. 1998; 17: 696-700.
9. Kalra V., Dua T., Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial. J Pediatr. 2003; 143: 111-114.
10. Singhi P., Jain V., Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol. 2004; 19: 323-327.
11. Gogia S., Talukdar B., Choudhury V., Arora BS Neurocysticercosis in children: Clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg. 2003; 97: 416-421.
12. Singhi P., Dayal D., Khandelwal N. One week versus four weeks of albendazole therapy for neurocysticercosis in children: A randomized, placebo-controlled double blind trial. Pediatr Infect Dis J. 2003; 22: 268-272.
13. Puri V., Sharma DK, Kumar S., Choudhury V., Gupta RK, Khalil A. Neurocysticercosis in children. Indian Pediatr. 1991; 28: 1309-1317.
14. Ferreira MS, Costa-Cruz JM, Nishioka SA, et al. Neurocysticercosis in Brazilian children: Report of 10 cases. Trop Med Parasitol. 1994; 45: 49-50.
15. Nazar N. Pediatric neurocysticercosis: Clinical features in Honduras. Rev Med Hondur. 1994; 62: 104-107.
16. del Brutto OH. Neurocysticercosis in children: Clinical and radiological analysis and prognostic factors in 54 patients. Rev Neurol. 1997; 25: 1681-1684.
17. Ruiz-Garcia M., Gonzalez-Astiazaran A., Rueda-Franco F. Neurocysticercosis in children: Clinical experience in 122 patients. Childs Nerv Syst. 1997; 13: 608-612.
18. Salazar OF, Cornejo W. Neurocysticercosis in children: Experiences in Medellin 1989-1996. Iatreia. 1997; 10: 99-105.
19. Cuellar R., Molinero M., Ramirez F., Vallejo V. Clinical findings in active cerebral neurocysticercosis in pediatrics. Rev Neurol. 1999; 29: 334-337.
20. Morales NM, Agapejev S., Morales RR, Padula NA, Lima MM Clinical aspects of neurocysticercosis in children. Pediatr Neurol. 2000; 22: 287-291.
21. Singhi P., Ray M., Singhi S., Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol. 2000; 15: 207-213.
22. Talukdar B., Saxena A., Popli VK, Choudhury V. Neurocysticercosis in children: Clinical characteristics and outcome. Ann Trop Paediatr. 2002; 22: 333-339.
23. de Bittencourt PR, Adamolekum B., Bharucha N., et al. Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia. 1996; 37: 1128-1137.
24. Miller B., Grinnell V., Goldberg MA, Heiner D. Spontaneous radiographic disappearance of cerebral cysticercosis: Three cases. Neurology. 1983; 33: 1377-1379.
25. Carpio A., Santillan F., Leon P., Flores C., Hauser WA Is the course of neurocysticercosis modified by treatment with antihelminthic agents ? Arch Intern Med. 1995; 155: 1982-1988.
26. Carpio A., Hauser WA Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. 2002; 59: 1730-1734.
27. Salinas R., Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of the brain). Cochrane Database Syst Rev. 2004; 4: CD000215.
28. Salinas R., Counsell C., Prasad K., Gelband H., Garner P. Treating neurocysticercosis medically: A systematic review of randomized, controlled trials. Trop Med Int Health. 1999; 4: 713-718.